Juan‐José Garcés

Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma

Ibai Goicoechea, Noemí Puig, María‐Teresa Cedena et al. · Blood · 2020 · 127 citations · Full text

Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)

Luzalba Sanoja-Flores, Juan Flores‐Montero, Juan‐José Garcés et al. · Blood Cancer Journal · 2018 · 119 citations · Full text

Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma

Juan‐José Garcés, María‐Teresa Cedena, Noemí Puig et al. · Journal of Clinical Oncology · 2022 · 105 citations · Full text

Transplant-eligible Multiple Myeloma, Hematological Malignancy, Cell Therapy +15

More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia–Like Multiple Myeloma

Tomáš Jelı́nek, Renata Bezděková, David Žihala et al. · Journal of Clinical Oncology · 2022 · 67 citations · Full text

Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination

Juan‐José Garcés, Michal Šimíček, Marco Vicari et al. · Leukemia · 2019 · 65 citations

Hematological Malignancy, Tumor Biology, Transcriptional Profiling +11